sbynews

DelMarVa’s Premier Source for Conservative News, Opinion, Analysis, and Human Interest

Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349

The opinions expressed by columnists are their own and do not represent our advertisers

AstraZeneca cops to rare, deadly side effect of COVID jab as lawsuits mount

AstraZeneca has admitted that its COVID-19 vaccine could cause a rare but deadly blood-clotting condition, potentially exposing the UK pharmaceutical giant to tens of millions in lawsuits brought by loved ones of those injured or killed as a result of the jab, according to court documents.

Lawyers representing “dozens” of class-action claimants say some of their clients’ cases could be worth as much as $25 million, calling the Cambridge-headquartered pharma firm’s vaccine “a defective product,” according to the Daily Mail.

AstraZeneca, which is contesting the claims, acknowledged in a February legal document that its vaccine can “in very rare cases” cause a condition called thrombosis with thrombocytopenia syndrome, or TTS.

TTS can cause patients to suffer blood clots as well as a low blood platelet count, which in some cases have seriously harmed or even killed recipients of the company’s vaccine.

More

1 thought on “AstraZeneca cops to rare, deadly side effect of COVID jab as lawsuits mount”

  1. Now they admit it………….after they are caught, They knew all along that vaccine was a killer.

Leave a Comment

Your email address will not be published. Required fields are marked *